PALO ALTO, Calif.--(BUSINESS WIRE)--Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, announced today that, in accordance with Nasdaq Marketplace rule 4350, the Company granted inducement stock options totaling 70,000 shares to three employees as set forth below:
